BB Biotech AG
BB Biotech's GHG Emissions Data Preview
In 2024, BB Biotech completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy), and Scope 3 (indirect emissions across the value chain).
BB Biotech has also provided a category-level breakdown for 5 out of 15 Scope 3 emissions categories, offering greater transparency into its value chain emissions.
| Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
|---|---|---|---|---|
Total Scope 1 | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Scope 2 | ||||
Unspecified Calculation Method | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Scope 3 | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
This table provides a simplified preview of selected GHG emissions data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.
Insights into BB Biotech's Operational Emissions
In 2024, the total operational greenhouse gas (GHG) emissions of BB Biotech amounted to 22 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).
Compared to 2023, the total operational greenhouse gas (GHG) emissions of BB Biotech decreased by 33.33%, showing that the company has made progress in taking action to reduce the climate impact of its operations.
BB Biotech's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are BB Biotech's Scope 1 emissions?
In 2024, the total Scope 1 emissions of BB Biotech were 12 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).
Has BB Biotech reduced its Scope 1 emissions over time?
Since 2020, BB Biotech's Scope 1 emissions have decreased by 62.5%, reflecting a declining long-term trend in Scope 1 emissions over time.
Compared to the previous year (2023), BB Biotech's Scope 1 emissions increased by 20%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations.
What are BB Biotech's Scope 2 emissions?
In 2024, BB Biotech reported Scope 2 greenhouse gas (GHG) emissions of 10 tCOâ‚‚e without specifying the calculation method.
Has BB Biotech reduced its Scope 2 emissions over time?
Since 2020, BB Biotech's Scope 2 greenhouse gas (GHG) emissions (Unspecified Calculation Method) have decreased by 77.27%, reflecting a declining long-term trend in Scope 2 emissions over time.
Compared to the previous year (2023), BB Biotech's Scope 2 emissions (Unspecified Calculation Method) fell by 56.52% in 2024, showing that the company has made progress in taking action to reduce the climate impact of its energy consumption.
What methodology does BB Biotech use for Scope 2 reporting?
In 2024, BB Biotech reported its Scope 2 emissions using an unspecified methodology.
BB Biotech's Scope 2 Emissions Over Time
- Total Scope 2 (Unspecified Calculation Method)
Insights into BB Biotech's Value Chain Emissions
In 2024, BB Biotech reported 581 metric tons of COâ‚‚ equivalent (tCOâ‚‚e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain.
The 2024 disclosure of BB Biotech includes a breakdown across 5 of the 15 Scope 3 categories defined by the GHG Protocol, matching the level of disclosure in 2023, demonstrating consistent Scope 3 emissions reporting coverage year over year.
BB Biotech's Scope 3 Emissions Over Time
- Total Scope 3
- Year-over-Year Change
What are BB Biotech's Scope 3 emissions?
In 2024, BB Biotech reported total Scope 3 emissions of 581 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).
Approximately 100% of these emissions originated from upstream activities such as purchased goods and capital goods, while 0% came from downstream activities like product use, distribution, and end-of-life treatment.
Has BB Biotech reduced its Scope 3 emissions over time?
Since 2020, BB Biotech's Scope 3 emissions have decreased by 19.86%, reflecting a declining long-term trend in Scope 3 emissions over time.
Compared to the previous year (2023), BB Biotech's Scope 3 emissions remained relatively stable, indicating that BB Biotech 's emissions have plateaued with no significant change in its value chain footprint.
What categories of Scope 3 emissions does BB Biotech disclose?
In 2024, BB Biotech reported emissions for 5 out of the 15 Scope 3 categories defined by the GHG Protocol.
This partial disclosure allows for some insight into the company's indirect impacts.
What are the main sources of BB Biotech's Scope 3 emissions?
In 2024, the largest contributors to BB Biotech's Scope 3 emissions were:
- Business Travel (Cat. 6): 471 tCOâ‚‚e (81.07%)
- Employee Commuting (Cat. 7): 70 tCOâ‚‚e (12.05%)
- Purchased Goods and Services (Cat. 1): 23 tCOâ‚‚e (3.96%)
BB Biotech's Scope 3 Emissions by Categories
Insights into BB Biotech's Total Carbon Footprint
In 2024, BB Biotech reported a total carbon footprint of 603 metric tons of COâ‚‚ equivalent (tCOâ‚‚e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 0.82% decrease compared to 2023, indicating progress in reducing its overall greenhouse gas output.
The largest contributor to BB Biotech's total carbon footprint was Scope 3 emissions, accounting for 96.35% of the company's total carbon footprint, followed by Scope 1 emissions at 1.99%.